comparemela.com
Home
Live Updates
Agendia, Inc.: Agendia Announces First Patient Enrolled in PROOFS Registry Trial to Determine Optimal Treatment and Ability to Forgo Chemotherapy for Premenopausal Women with Early HR+ Breast Cancer : comparemela.com
Agendia, Inc.: Agendia Announces First Patient Enrolled in PROOFS Registry Trial to Determine Optimal Treatment and Ability to Forgo Chemotherapy for Premenopausal Women with Early HR+ Breast Cancer
Agendia partners with the West German Study Group to determine the benefit of ovarian function suppression, potentially reducing overtreatment with chemotherapy Trial reinforces Agendia's
Related Keywords
Germany ,
West German ,
Dennis Riedl ,
William Audeh ,
Oleg Gluz ,
Kerry Harrington ,
German Study Group ,
Agendia Inc ,
University Of Cologne ,
Breast Center Niederrhein ,
West German Study Group ,
Mammaprint Low Risk ,
Scientific Director ,
Hospital Bethesda ,
Chief Medical Officer ,
Agendia ,
Nnounces ,
First ,
Patient ,
Unrolled ,
Roofs ,
Registry ,
Trial ,
Etermine ,
Toptimal ,
Treatment ,
Ability ,
Corgo ,
Chemotherapy ,
Premenopausal ,
Women ,
Early ,
Breast ,
Dancer ,
comparemela.com © 2020. All Rights Reserved.